At the end of the Supreme Court’s Opinion, Justice Thomas makes it clear that the Court was impressed by Judge Byson’s dissents in the Fed. Cir. Myriad opinions. Although Judge Bryson was on the Intema panel that sank claims to pre-natal screening for Down’s syndrome, the Supreme Court’s opinion makes his position in Myriad sound [...]
The post Can AMP v. Myriad Revive Diagnostic Method Claims? appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.